People with Down syndrome carry an extra copy of chromosome 21. But it has been unclear which genes within this dense package of DNA are responsible for the disorder, which includes mental retardation, early onset Alzheimer’s disease and other health problems. In a paper published today in Nature Neuroscience, researchers identified two crucial genes, called Olig1 and Olig2, involved in Down syndrome. Reducing the activity of these genes in mice engineered to mimic the disorder helps correct abnormal brain activity in these animals, a problem that is also present in people with the disorder.
“We hope the findings will lead to better strategies for early intervention, even during the pregnancy, to reduce neurological consequences of Down syndrome,” said Zygmunt Galdzicki, associate professor of Anatomy, Physiology and Genetics at Uniformed Services University of the Health Sciences, in a statement from the university. “These findings show the need to do more human studies and also suggest that Olig1 and Olig2 inhibitors may have a potential therapeutic role for Down syndrome individuals.”
The worst technology of 2021
Face filters, billionaires in space, and home-buying algorithms that overpay all made our annual list of technology gone wrong.
A horrifying new AI app swaps women into porn videos with a click
Deepfake researchers have long feared the day this would arrive.
Meet Altos Labs, Silicon Valley’s latest wild bet on living forever
Funders of a deep-pocketed new "rejuvenation" startup are said to include Jeff Bezos and Yuri Milner.
A gene-edited pig’s heart has been transplanted into a human for the first time
The procedure is a one-off, and highly experimental, but the technique could help reduce transplant waiting lists in the future.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.